BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9696017)

  • 1. Endothelin 1 aggravates acute liver injury in perfused livers of rats after treatment with D-galactosamine.
    Iwai M; Yamauchi T; Shimazu T
    Hepatology; 1998 Aug; 28(2):503-9. PubMed ID: 9696017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggravating action of zymosan on acute liver damage in perfused liver of rats treated with D-galactosamine.
    Cui TX; Iwai M; Yamauchi T; Shimazu T
    Am J Physiol; 1998 Dec; 275(6):G1361-6. PubMed ID: 9843773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exaggeration of acute liver damage by hepatic sympathetic nerves and circulating catecholamines in perfused liver of rats treated with D-galactosamine.
    Iwai M; Shimazu T
    Hepatology; 1996 Mar; 23(3):524-9. PubMed ID: 8617432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor subtype mediating the action of circulating endothelin on glucose metabolism and hemodynamics in perfused rat liver.
    Cui TX; Iwai M; Hamai M; Shimazu T
    Regul Pept; 1999 Sep; 83(2-3):117-22. PubMed ID: 10511465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggravation of chemically-induced injury in perfused rat liver by extracellular ATP.
    Cui TX; Iwai M; Hamai M; Minokoshi Y; Shimazu T; Horiuchi M
    Life Sci; 2000 May; 66(26):2593-601. PubMed ID: 10883737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraportal nicotine infusion in rats decreases hepatic blood flow through endothelin-1 and both endothelin A and endothelin B receptors.
    Hashimoto T; Yoneda M; Shimada T; Kurosawa M; Terano A
    Toxicol Appl Pharmacol; 2004 Apr; 196(1):1-10. PubMed ID: 15050402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats.
    Xu H; Korneszczuk K; Karaa A; Lin T; Clemens MG; Zhang JX
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G277-83. PubMed ID: 15647606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver.
    Reichen J; Gerbes AL; Steiner MJ; Sägesser H; Clozel M
    J Hepatol; 1998 Jun; 28(6):1020-30. PubMed ID: 9672179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of thromboxane in producing portal hypertension following trauma-hemorrhage.
    Yokoyama Y; Toth B; Kitchens WC; Schwacha MG; Bland KI; Chaudry IH
    Am J Physiol Gastrointest Liver Physiol; 2003 Dec; 285(6):G1293-9. PubMed ID: 14613921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alanine protects liver from injury caused by F-galactosamine and CCl4.
    Maezono K; Kajiwara K; Mawatari K; Shinkai A; Torii K; Maki T
    Hepatology; 1996 Jul; 24(1):185-91. PubMed ID: 8707260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats.
    Sogni P; Moreau R; Gomola A; Gadano A; Cailmail S; Calmus Y; Clozel M; Lebrec D
    Hepatology; 1998 Sep; 28(3):655-9. PubMed ID: 9731554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiated hepatic microcirculatory response to endothelin-1 during polymicrobial sepsis.
    Baveja R; Kresge N; Ashburn JH; Keller S; Yokoyama Y; Sonin N; Zhang JX; Huynh T; Clemens MG
    Shock; 2002 Nov; 18(5):415-22. PubMed ID: 12412619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exogenous endothelin-1 application on liver perfusion in native and transplanted porcine livers.
    Kraus T; Mehrabi A; Golling M; Schäffer F; Bud O; Gebhard MM; Herfarth C; Klar E
    J Surg Res; 2000 Oct; 93(2):272-81. PubMed ID: 11027470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective and non-selective endothelin antagonists on ischemia-reperfusion damage in the isolated perfused murine liver.
    Tanaka K; Higuchi H; Karasawa F; Sato T
    Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):129-38. PubMed ID: 10461680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure.
    Anand R; Harry D; Holt S; Milner P; Dashwood M; Goodier D; Jarmulowicz M; Moore K
    Gut; 2002 Jan; 50(1):111-7. PubMed ID: 11772977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of Indigofera tinctoria L. against D-Galactosamine and carbon tetrachloride challenge on 'in situ' perfused rat liver.
    Sreepriya M; Devaki T; Nayeem M
    Indian J Physiol Pharmacol; 2001 Oct; 45(4):428-34. PubMed ID: 11883148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic studies in experimental liver disease resulting from D(+)-galactosamine administration.
    Record CO; Alberti KG; Williamson DH
    Biochem J; 1972 Nov; 130(1):37-44. PubMed ID: 4655444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 and -3 induce choleresis in the rat through ETB receptors coupled to nitric oxide and vagovagal reflexes.
    Rodriguez MR; Soria LR; Ventimiglia MS; Najenson AC; Di María A; Dabas P; Fellet A; Marinelli RA; Vatta MS; Bianciotti LG
    Clin Sci (Lond); 2013 Dec; 125(11):521-32. PubMed ID: 23642207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygenation injury in the perfused rat liver.
    Wettstein M; Häussinger D
    Hepatology; 1997 Dec; 26(6):1560-6. PubMed ID: 9397998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous ET-1 contributes to liver injury induced by galactosamine and endotoxin in isolated perfused rat liver.
    Ohuchi T; Tada K; Akamatsu K
    Am J Physiol; 1995 Jun; 268(6 Pt 1):G997-1003. PubMed ID: 7611421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.